Skip to main content
. Author manuscript; available in PMC: 2009 Sep 25.
Published in final edited form as: Bioorg Med Chem. 2008 Nov 9;17(1):149–164. doi: 10.1016/j.bmc.2008.11.008

Table 6.

CoMFA statistics for TFK-inhibitors in ketone conformationa

Enzyme q2 spress m r2 SE log P log P2 Corr No.
Data for 5 min Ki incubation
hiCEb 0.447 1.010 4 0.952 0.299 37a
0.789 0.624 4 0.969 0.241 38a
0.803 0.603 4 0.969 0.237 39a
hCE1c 0.638 0.612 4 0.968 0.181 40a
0.822 0.429 4 0.979 0.146 41a
0.825 0.425 4 0.982 0.137 42a
rCEd 0.673 0.528 4 0.957 0.191 43a
0.861 0.345 4 0.966 0.171 44a
0.859 0.347 4 0.969 0.161 45a
Data for 24 h Ki incubation
hiCE 0.296 0.918 4 0.986 0.128 37b
0.115 1.029 4 0.976 0.169 38b
0.112 1.031 4 0.975 0.171 39b
hCE1 0.563 0.374 3 0.912 0.168 40b
0.606 0.342 2 0.849 0.212 41b
0.623 0.362 4 0.950 0.132 42b
rCE 0.099 0.959 3 0.968 0.180 43b
−0.135 0.963 1 0.230 0.793 44b
−0.134 0.963 1 0.146 0.836 45b
a

The parameters employed in the CoMFA analysis are indicated as included (○), or not included (—) in the generation of the final equation. The statistical quality of the models is described in terms of: q = leave-one-out cross-validated correlation coefficient, spress = cross-validated standard error, m = number of components, r = conventional correlation coefficient, SE = conventional standard error.

b

Correlation 39a was selected as the best correlation and is shown as Eq. (10b) and displayed in Figure 3.

c

Correlation 42a was selected as the best correlation and is shown as Eq. (11b) and displayed in Figure 3.

d

Correlation 45a was selected as the best correlation and is shown as Eq. (12b) and displayed in Figure 3.